News
Cells have a mailing system of sorts. They can release tiny molecular balls, called extracellular vesicles (EVs), that ...
Yet, despite more than 20 years of study, the sweet receptor’s precise architecture remained elusive, even as scientists ...
A research team has uncovered a previously unknown type of immune signaling molecule—a novel compound combining histidine and ...
Yale researchers have now developed a method to map and measure the structure of RNA as it develops, an advance that may help ...
New hollow dodecahedral shell demonstrates remarkable stability and potential for functionalization and encapsulating ...
Phase 2b ACCESS and ACCESS II studies anticipated by year-end 2025 Oral small molecule amylin receptor agonist (ACCG-2671) Phase 1 initiation anticipated by year-end 2025; New preclinical data to be ...
Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...
Today, most of us carry a fairly powerful computer in our hand—a smartphone.But computers weren't always so portable. Since ...
A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...
A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results